- Supported exchanges /
- ST /
- LIPUM.ST
Lipum AB (LIPUM ST) stock market data APIs
Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of juvenile idiopathic arthritis and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116; and a collaboration with the Karolinska Institute to explore the role of bile salt-stimulated lipase in the immune system in general and in rheumatoid arthritis in particular. The company was incorporated in 2010 and is based in Umeå, Sweden.
Lipum AB Financial Data Overview
| 16.68 | |
| 16.38 | |
| - | |
| 17.54 | |
| 16.52 | |
| 5.5-18.4 | |
| 363 M | |
| 21 212 K | |
| 53 000 | |
| -0.0785 | |
| 0.151 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Lipum AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 53 000
- EBITDA -39 286 000
- Earnings Per Share -2.77
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Lipum AB Earnings via APIs
- Latest Release 2024-10-25
- EPS/Forecast NaN
Get Lipum AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
